Matthew Pauls | President, CEO & Director |
Brian Davis | CFO |
Fredric Cohen | Chief Medical Officer |
Hartaj Singh | Oppenheimer & Co. |
Liisa Bayko | JMP Securities LLC |
Justin Kim | Cantor Fitzgerald & Co. |
Annabel Samimy | Stifel Nicolaus & Company |
Good day ladies and gentlemen, and welcome to the Strongbridge Biopharma's Fourth Quarter and Year-end 2017 Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct the question-and-answer session and instructions will be given at that time. [Operator Instructions].
As a reminder, this call is being recorded.